The international antidoping system and why it works

Clinical Chemistry

Volumn 55, Issue 8, 2009, Pages 1456-1461

  Bowers, Larry D ^a  

^a United States Anti Doping Agency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; EPITESTOSTERONE; GROWTH HORMONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; TESTOSTERONE; TETRAHYDROGESTRINONE;

ARTICLE; ATHLETE; DOPING; EDUCATION; ETHICS; MEDICAL SOCIETY; PHYSICAL PERFORMANCE; POLICY;

DOPING IN SPORTS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERNATIONAL AGENCIES; INTERNATIONAL COOPERATION; SUBSTANCE ABUSE DETECTION;

EID: 68149157900     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.127837     Document Type: Article

References (34)

1. McGrath JC, Cowan DA. Drugs in sport. Br J Pharmacol 2008;154:493-724.
2. Sport doping explored [Issue title]. J Mass Spectrom 2008;43:839-1020.
3. Kayser B, Smith AC. Globalisation of anti-doping: the reverse side of the medal. BMJ 2008;337:a584. (Pubitemid 352017228)
4. Kayser B, Mauron A, Miah A. Current anti-doping policy: a critical appraisal. BMC Med Ethics 2007; 8:2. (Pubitemid 46599033)
5. Murray TH. Enhancement. In: Steinbock B, ed. Oxford handbook of bioethics. New York: Oxford University Press; 2007. p 491-515.
6. World Anti-Doping Agency. World anti-doping code. Vol.3.0. Montreal (Canada): World Anti- Doping Agency; 2007.
7. United Nations Education Science, and Cultural Organization. International convention against doping in sport. 2005.
8. World Anti-Doping Agency. The 2009 Prohibited List International Standard. Montreal (Canada): World Anti-Doping Agency; 2009. p 9.
9. World Anti-Doping Agency. International Standard for Laboratories. Version 6.0. Montreal (Canada): World Anti-Doping Agency; 2009. p 88.
10. World Anti-Doping Agency. International Standard for Testing. Montreal (Canada): World Anti- Doping Agency; 2009. p 91.
11. World Anti-Doping Agency. International Standard for Therapeutic Use Exemptions. Version 2.0. Montreal (Canada): World Anti-Doping Agency; 2009. p 19.
12. World Anti-Doping Agency. International Standard for the Protection of Privacy and Personal Information. Version 1.0. Montreal (Canada): World Anti-Doping Agency; 2009. p 17.
13. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997;43:1262-1279 (Pubitemid 27297278)
14. Thevis M, Maurer J, Kohler M, Geyer H, Schänzer W. Proteases in doping control analysis. Int J Sports Med 2007;28:545-549
15. Ivanova V, Boghosian T, Rabin O. The WADA Proficiency Testing Program as an integral part of the fight against doping in sport. Accreditation Quality Assurance 2007;12:491-493
16. Beckett AH, Tucker GT, Moffat AC. Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. J Pharm Pharmacol 1967;19:273.
17. Bowers LD. The analytical chemistry of drug monitoring in athletes. Annu Rev Anal Chem. Forthcoming 2009;2.
18. Black RS, Bowers LD. A potential case of fluvoxamine-induced inhibition of caffeine metabolism. In: Schänzer W, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis. Vol.7. Köln: Sport und Buch Strauß; 1999. p 81-84
19. Berry DA. The science of doping. Nature 2008; 454:692-693
20. A level playing field [Editorial]? Nature 2008; 454:667.
21. Sottas PE, Saudan C, Schweizer C, Baume N, Mangin P, Saugy M. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. Forensic Sci Int 2008;174:166-172
22. Laidler P, Cowan DA, Hider RC, Kicman AT. New decision limits and quality-control material for detecting human chorionic gonadotropin misuse in sports. Clin Chem 1994;40:1306-1311 (Pubitemid 24205949)
23. Baenziger J, Bowers LD. Variability of T/E ratios in athletes. In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S, eds. Recent advances in doping analysis. Vol.2. Köln: Verlag Sport und BUCH Strauß; 1994. p 41-52.
24. Ayotte C, Goudreault D, Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J Chromatogr B Biomed Appl 1996;687:3-25. (Pubitemid 27008303)
25. Sottas PE, Baume N, Saudan C, Schweizer C, Kamber M, Saugy M. Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio. Biostatistics 2007;8: 285-296 (Pubitemid 46569590)
26. Ayotte C. Suivi des profils de steroides urinaires dans le controle du dopage des sportifs. Revue Francophone des Laboratoires 2008;401: 39-46.
27. Cawley AT, Flenker U. The application of carbon isotope ratio mass spectrometry to doping control. J Mass Spectrom 2008;43:854-864 (Pubitemid 352029654)
28. Walker CJ, Cowan DA, James VH, Lau JC, Kicman AT. Doping in sport-1: excretion of 19- norandrosterone by healthy women, including those using contraceptives containing norethisterone. Steroids 2009;74:329-334
29. Erotokritou-Mulligan I, Bassett EE, Bartlett C, Cowan D, McHugh C, Seah R, et al. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J Clin Endocrinol Metab 2008;93:2760-2763 (Pubitemid 352008548)
30. Bidlingmaier M, Suhr J, Ernst A, Wu Z, Keller A, Strasburger CJ, Bergmann A. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin Chem 2009;55:445-453
31. Landis F, Mooney LC. Positively false: the real story of how I won the Tour de France. New York: Simon and Schuster; 2007.
32. Floyd Landis v. United States Anti-Doping Agency. Vol.CAS 2007/A/1394 (Court of Arbitration for Sport, 2008).
33. Downes G. Concurrent expert evidence in the administrative appeals tribunal: the New South Wales Experience. Hobart (Australia): Australasian Conference of Planning and Environmental Courts and Tribunals; 2004.
34. Baker A. The Wiki Defense: how the French lab (LNDD), US Anti-Doping Agency, and AAA arbitrators failed: Floyd Landis doping test 995474: the science summarized. 2nd ed. Revision 73. http://www.arniebakercycling.com/books/wiki. htm (Accessed July 2009).